Diabetes Kongress 2019
zur Liste
Dr. William Abraham
The Ohio State University United States
  • Vortrag Design of the Effect of EMPaglifozin on ExeRcise ability and HF-symptoms, In patients with chronic heArt faiLure (EMPERIAL) trials of empagliflozin in patients with chronic heart failure with reduced or preserved ejection fraction Speaker
    Datum: 31.05.2019 , Zeit: 11:40 | Thema: 03. Grundlagenforschung Typ-1-Diabetes/ Betazelle/ Typ-1-Diabetes/ Adipositas/ Fettgewebe